Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
16201
16202
16203
16204
16205
16206
16207
16208
16209
16210
16211
16212
16213
16214
16215
16216
16217
16218
16219
16220
16221
16222
16223
16224
16225
16226
16227
16228
16229
16230
16231
16232
16233
16234
16235
16236
16237
16238
16239
16240
16241
16242
16243
16244
16245
16246
16247
16248
16249
16250
16251
16252
16253
16254
16255
16256
16257
16258
16259
16260
16261
16262
16263
16264
16265
16266
16267
16268
16269
16270
16271
16272
16273
16274
16275
16276
16277
16278
16279
16280
16281
16282
16283
16284
16285
16286
16287
16288
16289
16290
16291
16292
16293
16294
16295
16296
16297
16298
16299
16300
16301
16302
16303
16304
16305
16306
16307
16308
16309
16310
16311
16312
16313
16314
16315
16316
16317
16318
16319
16320
16321
16322
16323
16324
16325
16326
16327
16328
16329
16330
16331
16332
16333
16334
16335
16336
16337
16338
16339
16340
16341
16342
16343
16344
16345
16346
16347
16348
16349
16350
16351
16352
16353
16354
16355
16356
16357
16358
16359
16360
16361
16362
16363
16364
16365
16366
16367
16368
16369
16370
16371
16372
16373
16374
16375
16376
16377
16378
16379
16380
16381
16382
16383
16384
16385
16386
16387
16388
16389
16390
16391
16392
16393
16394
16395
16396
16397
16398
16399
16400
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1094 | 1149 | 1.4E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1152 | 1202 | 3.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 758 | 806 | 2.8E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1010 | 1034 | 2.2E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 710 | 754 | 2.2E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 619 | 667 | 5.5E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/1208|m.726 | UnnamedSample_HQ_transcript/1208 | Coverage 0.649 too low. | ab0262b88d8802908726a484d1ba2e84 | 1852 | Pfam | PF00053 | Laminin EGF domain | 1299 | 1337 | 4.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/13961|m.5101 | UnnamedSample_HQ_transcript/13961 | Unmapped. | fc624a5335d22d658ec0baa4637972d4 | 881 | Pfam | PF13087 | AAA domain | 135 | 306 | 6.0E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/5898|m.2501 | UnnamedSample_HQ_transcript/5898 | Identity 0.905 too low. | e2a710368a8114a12c1d485faa90fbb3 | 1259 | Pfam | PF00567 | Tudor domain | 1071 | 1190 | 4.6E-20 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/5898|m.2501 | UnnamedSample_HQ_transcript/5898 | Identity 0.905 too low. | e2a710368a8114a12c1d485faa90fbb3 | 1259 | Pfam | PF00567 | Tudor domain | 905 | 970 | 5.4E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/5898|m.2501 | UnnamedSample_HQ_transcript/5898 | Identity 0.905 too low. | e2a710368a8114a12c1d485faa90fbb3 | 1259 | Pfam | PF00567 | Tudor domain | 652 | 776 | 4.1E-17 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/5898|m.2501 | UnnamedSample_HQ_transcript/5898 | Identity 0.905 too low. | e2a710368a8114a12c1d485faa90fbb3 | 1259 | Pfam | PF12872 | OST-HTH/LOTUS domain | 7 | 61 | 2.0E-7 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/38472|m.11502 | UnnamedSample_HQ_transcript/38472 | Coverage 0.484 too low. | 548ad903693f515d69c73f78900cfa25 | 535 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 454 | 521 | 8.0E-25 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/38472|m.11502 | UnnamedSample_HQ_transcript/38472 | Coverage 0.484 too low. | 548ad903693f515d69c73f78900cfa25 | 535 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 2.0E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/34079|m.10484 | UnnamedSample_HQ_transcript/34079 | Coverage 0.071 too low. | fd9de7ca4ff3d88362d079016f51938c | 767 | Pfam | PF00069 | Protein kinase domain | 489 | 743 | 3.7E-40 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/72860|m.18451 | UnnamedSample_HQ_transcript/72860 | Coverage 0.934 too low. | 511a3a1e22d79802eeb594897966e6f7 | 313 | Pfam | PF10230 | Lipid-droplet associated hydrolase | 35 | 291 | 5.8E-63 | T | 22-09-2020 | IPR019363 | Lipid droplet-associated hydrolase |
| UnnamedSample_HQ_transcript/9900|m.3794 | UnnamedSample_HQ_transcript/9900 | Coverage 0.323 too low. | 26a56221c1e65b6dd8bb85f4cee894ed | 364 | Pfam | PF00365 | Phosphofructokinase | 8 | 266 | 8.4E-87 | T | 22-09-2020 | IPR000023 | Phosphofructokinase domain |
| UnnamedSample_HQ_transcript/12527|m.4672 | UnnamedSample_HQ_transcript/12527 | Coverage 0.123 too low. | aea6eb435408eba3f047e754e60c6364 | 1057 | Pfam | PF02185 | Hr1 repeat | 287 | 349 | 5.5E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12527|m.4672 | UnnamedSample_HQ_transcript/12527 | Coverage 0.123 too low. | aea6eb435408eba3f047e754e60c6364 | 1057 | Pfam | PF02185 | Hr1 repeat | 74 | 130 | 2.4E-8 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12527|m.4672 | UnnamedSample_HQ_transcript/12527 | Coverage 0.123 too low. | aea6eb435408eba3f047e754e60c6364 | 1057 | Pfam | PF02185 | Hr1 repeat | 192 | 256 | 3.4E-14 | T | 22-09-2020 | IPR011072 | HR1 rho-binding domain |
| UnnamedSample_HQ_transcript/12527|m.4672 | UnnamedSample_HQ_transcript/12527 | Coverage 0.123 too low. | aea6eb435408eba3f047e754e60c6364 | 1057 | Pfam | PF00069 | Protein kinase domain | 730 | 988 | 9.8E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/12527|m.4672 | UnnamedSample_HQ_transcript/12527 | Coverage 0.123 too low. | aea6eb435408eba3f047e754e60c6364 | 1057 | Pfam | PF00433 | Protein kinase C terminal domain | 1010 | 1052 | 1.8E-10 | T | 22-09-2020 | IPR017892 | Protein kinase, C-terminal |
| UnnamedSample_HQ_transcript/107671|m.23542 | UnnamedSample_HQ_transcript/107671 | Identity 0.537 too low. | 84e90eb8d79fb0b457bbd31f8a0fa84d | 182 | Pfam | PF13833 | EF-hand domain pair | 116 | 145 | 0.0018 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/107671|m.23542 | UnnamedSample_HQ_transcript/107671 | Identity 0.537 too low. | 84e90eb8d79fb0b457bbd31f8a0fa84d | 182 | Pfam | PF13833 | EF-hand domain pair | 152 | 176 | 0.0071 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/112739|m.24162 | UnnamedSample_HQ_transcript/112739 | Coverage 0.967 too low. | 84e90eb8d79fb0b457bbd31f8a0fa84d | 182 | Pfam | PF13833 | EF-hand domain pair | 116 | 145 | 0.0018 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/112739|m.24162 | UnnamedSample_HQ_transcript/112739 | Coverage 0.967 too low. | 84e90eb8d79fb0b457bbd31f8a0fa84d | 182 | Pfam | PF13833 | EF-hand domain pair | 152 | 176 | 0.0071 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/77596|m.19306 | UnnamedSample_HQ_transcript/77596 | Coverage 0.534 too low. | 54940c955e07a32e46ee9c6525e3d727 | 451 | Pfam | PF00012 | Hsp70 protein | 1 | 451 | 7.2E-179 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/32038|m.9960 | UnnamedSample_HQ_transcript/32038 | Coverage 0.524 too low. | d3ddbd8e43205a00ee5dbd09669af36f | 549 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 2.1E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/34854|m.10687 | UnnamedSample_HQ_transcript/34854 | Identity 0.704 too low. | 33ab6789ced514ad0c42489744ae268b | 203 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 2 | 185 | 1.2E-77 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/81042|m.19889 | UnnamedSample_HQ_transcript/81042 | Coverage 0.967 too low. | de0236ffb1b73ae6117a5efa5de3cd13 | 128 | Pfam | PF00125 | Core histone H2A/H2B/H3/H4 | 7 | 94 | 3.2E-19 | T | 22-09-2020 | IPR007125 | Histone H2A/H2B/H3 |
| UnnamedSample_HQ_transcript/81042|m.19889 | UnnamedSample_HQ_transcript/81042 | Coverage 0.967 too low. | de0236ffb1b73ae6117a5efa5de3cd13 | 128 | Pfam | PF16211 | C-terminus of histone H2A | 95 | 126 | 4.7E-13 | T | 22-09-2020 | IPR032454 | Histone H2A, C-terminal domain |
| UnnamedSample_HQ_transcript/16337|m.5810 | UnnamedSample_HQ_transcript/16337 | Coverage 0.053 too low. | 82fc8124b2d7595bac865828b78cdcb1 | 733 | Pfam | PF02188 | GoLoco motif | 55 | 75 | 3.6E-8 | T | 22-09-2020 | IPR003109 | GoLoco motif |
| UnnamedSample_HQ_transcript/16337|m.5810 | UnnamedSample_HQ_transcript/16337 | Coverage 0.053 too low. | 82fc8124b2d7595bac865828b78cdcb1 | 733 | Pfam | PF02145 | Rap/ran-GAP | 300 | 480 | 5.9E-70 | T | 22-09-2020 | IPR000331 | Rap GTPase activating protein domain |
| UnnamedSample_HQ_transcript/42389|m.12347 | UnnamedSample_HQ_transcript/42389 | Coverage 0.051 too low. | 9ba442d36ef84c920fbed371f93b9249 | 215 | Pfam | PF03165 | MH1 domain | 59 | 143 | 1.4E-22 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF01682 | DB module | 172 | 265 | 1.4E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF01682 | DB module | 409 | 500 | 4.9E-14 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF01682 | DB module | 1121 | 1207 | 8.9E-15 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF01682 | DB module | 618 | 709 | 9.3E-17 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF07686 | Immunoglobulin V-set domain | 35 | 129 | 3.1E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF00041 | Fibronectin type III domain | 719 | 806 | 1.4E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF00041 | Fibronectin type III domain | 828 | 907 | 2.0E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF00041 | Fibronectin type III domain | 274 | 376 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF00041 | Fibronectin type III domain | 510 | 589 | 4.2E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7777|m.3113 | UnnamedSample_HQ_transcript/7777 | Coverage 0.082 too low. | 1b50c7a41decb069aac5d44c2d0c48b5 | 1266 | Pfam | PF07679 | Immunoglobulin I-set domain | 1021 | 1109 | 1.4E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/37008|m.11169 | UnnamedSample_HQ_transcript/37008 | Coverage 0.980 too low. | 219cea3623ca5f339a2e2fc680bb8a57 | 574 | Pfam | PF00615 | Regulator of G protein signaling domain | 2 | 110 | 1.8E-6 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF07686 | Immunoglobulin V-set domain | 35 | 129 | 3.3E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF01682 | DB module | 618 | 709 | 1.0E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF01682 | DB module | 409 | 500 | 5.3E-14 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF01682 | DB module | 1121 | 1207 | 9.1E-15 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF01682 | DB module | 172 | 265 | 1.5E-16 | T | 22-09-2020 | IPR002602 | Domain of unknown function DB |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF07679 | Immunoglobulin I-set domain | 1021 | 1109 | 1.5E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF00041 | Fibronectin type III domain | 828 | 907 | 2.2E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF00041 | Fibronectin type III domain | 1217 | 1295 | 7.8E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF00041 | Fibronectin type III domain | 510 | 589 | 4.5E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF00041 | Fibronectin type III domain | 719 | 806 | 8.1E-11 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/6536|m.2719 | UnnamedSample_HQ_transcript/6536 | Coverage 0.080 too low. | 75591677069af7442ae02f89931e728a | 1349 | Pfam | PF00041 | Fibronectin type III domain | 274 | 376 | 1.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/15564|m.5573 | UnnamedSample_HQ_transcript/15564 | Coverage 0.676 too low. | 3e19909caba35833183aeb5227bf4bb5 | 990 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 776 | 983 | 5.4E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/15564|m.5573 | UnnamedSample_HQ_transcript/15564 | Coverage 0.676 too low. | 3e19909caba35833183aeb5227bf4bb5 | 990 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 130 | 407 | 3.8E-36 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/15564|m.5573 | UnnamedSample_HQ_transcript/15564 | Coverage 0.676 too low. | 3e19909caba35833183aeb5227bf4bb5 | 990 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 558 | 694 | 9.8E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/89248|m.21120 | UnnamedSample_HQ_transcript/89248 | Coverage 0.676 too low. | f8c3ce4eceac00debd6b439baadb4966 | 426 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 126 | 426 | 9.8E-56 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/115305|m.24429 | UnnamedSample_HQ_transcript/115305 | Coverage 0.230 too low. | 37331da671abbae3248d5aec96aa71a3 | 233 | Pfam | PF00335 | Tetraspanin family | 20 | 231 | 5.0E-22 | T | 22-09-2020 | IPR018499 | Tetraspanin/Peripherin |
| UnnamedSample_HQ_transcript/78690|m.19499 | UnnamedSample_HQ_transcript/78690 | Coverage 0.328 too low. | 874176eb92acabbe98f73dc5e6cf0195 | 208 | Pfam | PF00970 | Oxidoreductase FAD-binding domain | 49 | 155 | 5.5E-34 | T | 22-09-2020 | IPR008333 | Flavoprotein pyridine nucleotide cytochrome reductase-like, FAD-binding domain |
| UnnamedSample_HQ_transcript/29065|m.9246 | UnnamedSample_HQ_transcript/29065 | Coverage 0.611 too low. | 9f082cacd58224f7236cfe2352b888d9 | 539 | Pfam | PF00899 | ThiF family | 18 | 511 | 3.1E-20 | T | 22-09-2020 | IPR000594 | THIF-type NAD/FAD binding fold |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 614 | 663 | 7.2E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 717 | 759 | 4.9E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 2 | 30 | 8.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 38 | 95 | 1.7E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 98 | 146 | 3.3E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 459 | 507 | 1.1E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 411 | 456 | 3.3E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 765 | 807 | 1.3E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 666 | 714 | 3.2E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 555 | 611 | 2.4E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/4380|m.1948 | UnnamedSample_HQ_transcript/4380 | Identity 0.890 too low. | 4c8ff1c9f6a7fe872abeabf2541f95be | 1409 | Pfam | PF00053 | Laminin EGF domain | 149 | 187 | 1.2E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/38163|m.11436 | UnnamedSample_HQ_transcript/38163 | Coverage 0.957 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00397 | WW domain | 393 | 422 | 3.8E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/38163|m.11436 | UnnamedSample_HQ_transcript/38163 | Coverage 0.957 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00397 | WW domain | 169 | 198 | 3.6E-12 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/38163|m.11436 | UnnamedSample_HQ_transcript/38163 | Coverage 0.957 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 589 | 720 | 2.0E-30 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/38163|m.11436 | UnnamedSample_HQ_transcript/38163 | Coverage 0.957 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00168 | C2 domain | 15 | 106 | 2.4E-14 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/40315|m.11914 | UnnamedSample_HQ_transcript/40315 | Coverage 0.987 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00397 | WW domain | 393 | 422 | 3.8E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/40315|m.11914 | UnnamedSample_HQ_transcript/40315 | Coverage 0.987 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00397 | WW domain | 169 | 198 | 3.6E-12 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/40315|m.11914 | UnnamedSample_HQ_transcript/40315 | Coverage 0.987 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 589 | 720 | 2.0E-30 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/40315|m.11914 | UnnamedSample_HQ_transcript/40315 | Coverage 0.987 too low. | b416261927930332c8498a0b015d1c9d | 720 | Pfam | PF00168 | C2 domain | 15 | 106 | 2.4E-14 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/69488|m.17842 | UnnamedSample_HQ_transcript/69488 | Coverage 0.783 too low. | 290cd27d68096deb347dd250d2f01e45 | 443 | Pfam | PF01189 | 16S rRNA methyltransferase RsmB/F | 224 | 397 | 4.4E-42 | T | 22-09-2020 | IPR001678 | SAM-dependent methyltransferase RsmB/NOP2-type |
| UnnamedSample_HQ_transcript/4915|m.2158 | UnnamedSample_HQ_transcript/4915 | Identity 0.840 too low. | 177f4e650abef9a023375356b0d73600 | 1450 | Pfam | PF08638 | Mediator complex subunit MED14 | 2 | 138 | 6.0E-40 | T | 22-09-2020 | IPR013947 | Mediator complex, subunit Med14 |
| UnnamedSample_HQ_transcript/73257|m.18517 | UnnamedSample_HQ_transcript/73257 | Identity 0.813 too low. | 44c6ade328c95af1b32154bcbad7999e | 377 | Pfam | PF00501 | AMP-binding enzyme | 1 | 347 | 3.5E-78 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/102354|m.22911 | UnnamedSample_HQ_transcript/102354 | Coverage 0.990 too low. | 44128057615834dcf8f707f450bfbd3b | 222 | Pfam | PF01058 | NADH ubiquinone oxidoreductase, 20 Kd subunit | 97 | 202 | 2.9E-22 | T | 22-09-2020 | IPR006137 | NADH:ubiquinone oxidoreductase-like, 20kDa subunit |
| UnnamedSample_HQ_transcript/13956|m.5100 | UnnamedSample_HQ_transcript/13956 | Coverage 0.986 too low. | e5d9fbc77d531f1507dc79a3fbfe2d29 | 1084 | Pfam | PF01388 | ARID/BRIGHT DNA binding domain | 520 | 607 | 2.0E-18 | T | 22-09-2020 | IPR001606 | ARID DNA-binding domain |
| UnnamedSample_HQ_transcript/10017|m.3836 | UnnamedSample_HQ_transcript/10017 | Coverage 0.820 too low. | c30da3aa95d830fe4cba0b9c6ac9c7bc | 629 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 2.9E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/10017|m.3836 | UnnamedSample_HQ_transcript/10017 | Coverage 0.820 too low. | c30da3aa95d830fe4cba0b9c6ac9c7bc | 629 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 1.8E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/10017|m.3836 | UnnamedSample_HQ_transcript/10017 | Coverage 0.820 too low. | c30da3aa95d830fe4cba0b9c6ac9c7bc | 629 | Pfam | PF17787 | PH domain | 12 | 139 | 1.3E-43 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/24049|m.7958 | UnnamedSample_HQ_transcript/24049 | Identity 0.873 too low. | 90c3d7b86e35d33c3193e7f7b51df83f | 875 | Pfam | PF02172 | KIX domain | 1 | 42 | 9.1E-12 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/24049|m.7958 | UnnamedSample_HQ_transcript/24049 | Identity 0.873 too low. | 90c3d7b86e35d33c3193e7f7b51df83f | 875 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 578 | 617 | 1.7E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/24049|m.7958 | UnnamedSample_HQ_transcript/24049 | Identity 0.873 too low. | 90c3d7b86e35d33c3193e7f7b51df83f | 875 | Pfam | PF00439 | Bromodomain | 484 | 566 | 2.2E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/24049|m.7958 | UnnamedSample_HQ_transcript/24049 | Identity 0.873 too low. | 90c3d7b86e35d33c3193e7f7b51df83f | 875 | Pfam | PF08214 | Histone acetylation protein | 728 | 873 | 1.6E-44 | T | 22-09-2020 | IPR013178 | Histone acetyltransferase Rtt109/CBP |
| UnnamedSample_HQ_transcript/15977|m.5699 | UnnamedSample_HQ_transcript/15977 | Coverage 0.381 too low. | 3a07217601c0d54dcd4198a94196dfad | 518 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 160 | 234 | 1.0E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/18356|m.6406 | UnnamedSample_HQ_transcript/18356 | Coverage 0.440 too low. | 3a07217601c0d54dcd4198a94196dfad | 518 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 160 | 234 | 1.0E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/13489|m.4949 | UnnamedSample_HQ_transcript/13489 | Coverage 0.411 too low. | 3a07217601c0d54dcd4198a94196dfad | 518 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 160 | 234 | 1.0E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/117245|m.24612 | UnnamedSample_HQ_transcript/117245 | Coverage 0.309 too low. | 69da1aba3c2f00c25ce95cfa7065500f | 136 | Pfam | PF09748 | Transcription factor subunit Med10 of Mediator complex | 10 | 126 | 4.2E-37 | T | 22-09-2020 | IPR019145 | Mediator complex, subunit Med10 |
| UnnamedSample_HQ_transcript/106750|m.23422 | UnnamedSample_HQ_transcript/106750 | Coverage 0.990 too low. | 8a7e95da06188afc7227237f1fb826fd | 152 | Pfam | PF11901 | Protein of unknown function (DUF3421) | 33 | 142 | 8.7E-44 | T | 22-09-2020 | IPR024518 | Domain of unknown function DUF3421 |
| UnnamedSample_HQ_transcript/17060|m.6025 | UnnamedSample_HQ_transcript/17060 | Coverage 0.378 too low. | 91e8da01dfa2572a0546214fc696a887 | 360 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.0E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/4402|m.1958 | UnnamedSample_HQ_transcript/4402 | Coverage 0.922 too low. | c6fbc6b8e0bc25f0817138d20bbb192e | 137 | Pfam | PF00069 | Protein kinase domain | 55 | 121 | 1.2E-13 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/4719|m.2080 | UnnamedSample_HQ_transcript/4719 | Identity 0.943 too low. | 80ec7c66da516ce80b352db4b94b7f58 | 1466 | Pfam | PF01562 | Reprolysin family propeptide | 52 | 169 | 6.5E-9 | T | 22-09-2020 | IPR002870 | Peptidase M12B, propeptide |
| UnnamedSample_HQ_transcript/4719|m.2080 | UnnamedSample_HQ_transcript/4719 | Identity 0.943 too low. | 80ec7c66da516ce80b352db4b94b7f58 | 1466 | Pfam | PF13574 | Metallo-peptidase family M12B Reprolysin-like | 458 | 643 | 2.8E-27 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4719|m.2080 | UnnamedSample_HQ_transcript/4719 | Identity 0.943 too low. | 80ec7c66da516ce80b352db4b94b7f58 | 1466 | Pfam | PF00200 | Disintegrin | 669 | 752 | 3.3E-12 | T | 22-09-2020 | IPR001762 | Disintegrin domain |
| UnnamedSample_HQ_transcript/5326|m.2311 | UnnamedSample_HQ_transcript/5326 | Identity 0.912 too low. | 41a1704910dc774500cdaf2332b21cf2 | 1503 | Pfam | PF00439 | Bromodomain | 1290 | 1372 | 4.3E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/5326|m.2311 | UnnamedSample_HQ_transcript/5326 | Identity 0.912 too low. | 41a1704910dc774500cdaf2332b21cf2 | 1503 | Pfam | PF02135 | TAZ zinc finger | 371 | 448 | 4.9E-20 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/5326|m.2311 | UnnamedSample_HQ_transcript/5326 | Identity 0.912 too low. | 41a1704910dc774500cdaf2332b21cf2 | 1503 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 1384 | 1423 | 3.2E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/5326|m.2311 | UnnamedSample_HQ_transcript/5326 | Identity 0.912 too low. | 41a1704910dc774500cdaf2332b21cf2 | 1503 | Pfam | PF02172 | KIX domain | 803 | 848 | 2.0E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/2745|m.1338 | UnnamedSample_HQ_transcript/2745 | Coverage 0.063 too low. | 911683511db735a5ada1ac3c835f9590 | 910 | Pfam | PF17817 | PDZ domain | 107 | 179 | 1.3E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/2745|m.1338 | UnnamedSample_HQ_transcript/2745 | Coverage 0.063 too low. | 911683511db735a5ada1ac3c835f9590 | 910 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 814 | 872 | 3.2E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/2745|m.1338 | UnnamedSample_HQ_transcript/2745 | Coverage 0.063 too low. | 911683511db735a5ada1ac3c835f9590 | 910 | Pfam | PF00595 | PDZ domain | 188 | 270 | 6.9E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/42779|m.12436 | UnnamedSample_HQ_transcript/42779 | Coverage 0.756 too low. | 3d7eb65137a5c7647c974adb3b70efc4 | 298 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 52 | 264 | 1.1E-39 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/34590|m.10626 | UnnamedSample_HQ_transcript/34590 | Coverage 0.614 too low. | 0cd88ab9eff3b8eb79b60a947b2d09a0 | 613 | Pfam | PF13176 | Tetratricopeptide repeat | 469 | 495 | 0.0018 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/34590|m.10626 | UnnamedSample_HQ_transcript/34590 | Coverage 0.614 too low. | 0cd88ab9eff3b8eb79b60a947b2d09a0 | 613 | Pfam | PF12895 | Anaphase-promoting complex, cyclosome, subunit 3 | 32 | 107 | 6.0E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6628|m.2750 | UnnamedSample_HQ_transcript/6628 | Unmapped. | 5738857211648a2592beecbf5576a69a | 1468 | Pfam | PF08762 | CRPV capsid protein like | 465 | 675 | 7.8E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/6628|m.2750 | UnnamedSample_HQ_transcript/6628 | Unmapped. | 5738857211648a2592beecbf5576a69a | 1468 | Pfam | PF00910 | RNA helicase | 1089 | 1197 | 5.2E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/74039|m.18649 | UnnamedSample_HQ_transcript/74039 | Coverage 0.412 too low. | 076579aa5fdfc61d38652bb2cbfdd188 | 442 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 32 | 420 | 4.3E-95 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/107553|m.23527 | UnnamedSample_HQ_transcript/107553 | Coverage 0.981 too low. | 0ccc2e97372a4da5d1edd6254ede0a73 | 234 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 38 | 108 | 2.4E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/2758|m.1345 | UnnamedSample_HQ_transcript/2758 | Unmapped. | ffb7293a1856034c2dac395fdf924bee | 1016 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 860 | 1.1E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/40899|m.12050 | UnnamedSample_HQ_transcript/40899 | Coverage 0.985 too low. | 8b465798f4eb055aca5a2e136bfec81c | 433 | Pfam | PF00400 | WD domain, G-beta repeat | 241 | 265 | 0.083 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/40899|m.12050 | UnnamedSample_HQ_transcript/40899 | Coverage 0.985 too low. | 8b465798f4eb055aca5a2e136bfec81c | 433 | Pfam | PF00400 | WD domain, G-beta repeat | 143 | 174 | 0.051 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/40899|m.12050 | UnnamedSample_HQ_transcript/40899 | Coverage 0.985 too low. | 8b465798f4eb055aca5a2e136bfec81c | 433 | Pfam | PF00400 | WD domain, G-beta repeat | 271 | 307 | 0.0036 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/76163|m.19057 | UnnamedSample_HQ_transcript/76163 | Coverage 0.989 too low. | 181d18126f2bcd112f735d2413950cf5 | 384 | Pfam | PF03781 | Sulfatase-modifying factor enzyme 1 | 103 | 380 | 5.2E-76 | T | 22-09-2020 | IPR005532 | Sulfatase-modifying factor enzyme |
| UnnamedSample_HQ_transcript/96947|m.22222 | UnnamedSample_HQ_transcript/96947 | Coverage 0.985 too low. | ad5b3c9e2d67bbfc7f270a01d2050095 | 329 | Pfam | PF16030 | Serine protease gd N-terminus | 41 | 146 | 1.1E-17 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/8421|m.3328 | UnnamedSample_HQ_transcript/8421 | Coverage 0.160 too low. | ca8349e44ce73ae8017566330d984cb2 | 1185 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 797 | 918 | 4.6E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/8421|m.3328 | UnnamedSample_HQ_transcript/8421 | Coverage 0.160 too low. | ca8349e44ce73ae8017566330d984cb2 | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 21 | 102 | 3.9E-15 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/8421|m.3328 | UnnamedSample_HQ_transcript/8421 | Coverage 0.160 too low. | ca8349e44ce73ae8017566330d984cb2 | 1185 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 186 | 757 | 3.1E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/97758|m.22330 | UnnamedSample_HQ_transcript/97758 | Coverage 0.984 too low. | da57eaae45cc60ce63f6c0fdffb96adc | 326 | Pfam | PF00168 | C2 domain | 182 | 289 | 3.7E-18 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/97758|m.22330 | UnnamedSample_HQ_transcript/97758 | Coverage 0.984 too low. | da57eaae45cc60ce63f6c0fdffb96adc | 326 | Pfam | PF00168 | C2 domain | 33 | 135 | 1.7E-20 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/92298|m.21579 | UnnamedSample_HQ_transcript/92298 | Coverage 0.128 too low. | da57eaae45cc60ce63f6c0fdffb96adc | 326 | Pfam | PF00168 | C2 domain | 182 | 289 | 3.7E-18 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/92298|m.21579 | UnnamedSample_HQ_transcript/92298 | Coverage 0.128 too low. | da57eaae45cc60ce63f6c0fdffb96adc | 326 | Pfam | PF00168 | C2 domain | 33 | 135 | 1.7E-20 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/9288|m.3602 | UnnamedSample_HQ_transcript/9288 | Coverage 0.103 too low. | 035c50050fa3612e60b60c78dfe62b5e | 200 | Pfam | PF00261 | Tropomyosin | 16 | 182 | 9.1E-63 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/23353|m.7777 | UnnamedSample_HQ_transcript/23353 | Coverage 0.944 too low. | 6e921ba05faef277d92d59b97a12a4d6 | 314 | Pfam | PF16066 | Domain of unknown function (DUF4808) | 54 | 185 | 1.8E-38 | T | 22-09-2020 | IPR032073 | Fibronectin type III domain-containing protein 5, C-terminal domain |
| UnnamedSample_HQ_transcript/23744|m.7877 | UnnamedSample_HQ_transcript/23744 | Identity 0.941 too low. | 528386fd80f7ee4cb791b575862c2b8d | 966 | Pfam | PF13086 | AAA domain | 838 | 933 | 3.6E-11 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/38452|m.11495 | UnnamedSample_HQ_transcript/38452 | Coverage 0.161 too low. | 0e978556356e91d41661b4fd7c74a3e0 | 651 | Pfam | PF00400 | WD domain, G-beta repeat | 454 | 489 | 0.039 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/38452|m.11495 | UnnamedSample_HQ_transcript/38452 | Coverage 0.161 too low. | 0e978556356e91d41661b4fd7c74a3e0 | 651 | Pfam | PF00400 | WD domain, G-beta repeat | 501 | 536 | 0.0029 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/38452|m.11495 | UnnamedSample_HQ_transcript/38452 | Coverage 0.161 too low. | 0e978556356e91d41661b4fd7c74a3e0 | 651 | Pfam | PF00400 | WD domain, G-beta repeat | 94 | 139 | 1.7E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/38452|m.11495 | UnnamedSample_HQ_transcript/38452 | Coverage 0.161 too low. | 0e978556356e91d41661b4fd7c74a3e0 | 651 | Pfam | PF00400 | WD domain, G-beta repeat | 613 | 649 | 0.018 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/38452|m.11495 | UnnamedSample_HQ_transcript/38452 | Coverage 0.161 too low. | 0e978556356e91d41661b4fd7c74a3e0 | 651 | Pfam | PF03451 | HELP motif | 18 | 90 | 8.3E-32 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/73529|m.18576 | UnnamedSample_HQ_transcript/73529 | Coverage 0.990 too low. | bce2a6d5f2cdfffafb30246c7eb856f9 | 500 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 125 | 191 | 6.6E-18 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/73529|m.18576 | UnnamedSample_HQ_transcript/73529 | Coverage 0.990 too low. | bce2a6d5f2cdfffafb30246c7eb856f9 | 500 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 241 | 305 | 1.9E-16 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/73529|m.18576 | UnnamedSample_HQ_transcript/73529 | Coverage 0.990 too low. | bce2a6d5f2cdfffafb30246c7eb856f9 | 500 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 35 | 99 | 1.0E-14 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/73529|m.18576 | UnnamedSample_HQ_transcript/73529 | Coverage 0.990 too low. | bce2a6d5f2cdfffafb30246c7eb856f9 | 500 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 331 | 395 | 1.4E-14 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/16814|m.5945 | UnnamedSample_HQ_transcript/16814 | Coverage 0.870 too low. | 7f27ebdbc3c5b7e7c2eb6dc8e49eba5e | 1102 | Pfam | PF01576 | Myosin tail | 846 | 1098 | 1.2E-28 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/16814|m.5945 | UnnamedSample_HQ_transcript/16814 | Coverage 0.870 too low. | 7f27ebdbc3c5b7e7c2eb6dc8e49eba5e | 1102 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.7E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/16814|m.5945 | UnnamedSample_HQ_transcript/16814 | Coverage 0.870 too low. | 7f27ebdbc3c5b7e7c2eb6dc8e49eba5e | 1102 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 1.2E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/79360|m.19603 | UnnamedSample_HQ_transcript/79360 | Coverage 0.829 too low. | bb89e8bb98c0b845ad9402ccf96edfdb | 424 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/79360|m.19603 | UnnamedSample_HQ_transcript/79360 | Coverage 0.829 too low. | bb89e8bb98c0b845ad9402ccf96edfdb | 424 | Pfam | PF00096 | Zinc finger, C2H2 type | 396 | 419 | 7.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/19555|m.6742 | UnnamedSample_HQ_transcript/19555 | Coverage 0.638 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF01061 | ABC-2 type transporter | 406 | 615 | 2.5E-47 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/19555|m.6742 | UnnamedSample_HQ_transcript/19555 | Coverage 0.638 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF19055 | ABC-2 type transporter | 282 | 349 | 3.5E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/19555|m.6742 | UnnamedSample_HQ_transcript/19555 | Coverage 0.638 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF00005 | ABC transporter | 99 | 253 | 2.2E-21 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/27939|m.8951 | UnnamedSample_HQ_transcript/27939 | Identity 0.840 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF01061 | ABC-2 type transporter | 406 | 615 | 2.5E-47 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/27939|m.8951 | UnnamedSample_HQ_transcript/27939 | Identity 0.840 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF19055 | ABC-2 type transporter | 282 | 349 | 3.5E-10 | T | 22-09-2020 | IPR043926 | ABC transporter family G domain |
| UnnamedSample_HQ_transcript/27939|m.8951 | UnnamedSample_HQ_transcript/27939 | Identity 0.840 too low. | 7d78ff30c220d7d518723416b507d98d | 678 | Pfam | PF00005 | ABC transporter | 99 | 253 | 2.2E-21 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/76016|m.19024 | UnnamedSample_HQ_transcript/76016 | Coverage 0.861 too low. | 870d4d04f7ef8e4d4598f087be08289c | 482 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 37 | 457 | 1.7E-77 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/89041|m.21089 | UnnamedSample_HQ_transcript/89041 | Coverage 0.842 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF17862 | AAA+ lid domain | 355 | 398 | 1.1E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/89041|m.21089 | UnnamedSample_HQ_transcript/89041 | Coverage 0.842 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 199 | 332 | 1.7E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/89041|m.21089 | UnnamedSample_HQ_transcript/89041 | Coverage 0.842 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 86 | 141 | 1.1E-10 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/80240|m.19754 | UnnamedSample_HQ_transcript/80240 | Coverage 0.858 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF17862 | AAA+ lid domain | 355 | 398 | 1.1E-10 | T | 22-09-2020 | IPR041569 | AAA ATPase, AAA+ lid domain |
| UnnamedSample_HQ_transcript/80240|m.19754 | UnnamedSample_HQ_transcript/80240 | Coverage 0.858 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 199 | 332 | 1.7E-43 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/80240|m.19754 | UnnamedSample_HQ_transcript/80240 | Coverage 0.858 too low. | 23f5cc1d7fae2117f80f272f621d540d | 415 | Pfam | PF16450 | Proteasomal ATPase OB C-terminal domain | 86 | 141 | 1.1E-10 | T | 22-09-2020 | IPR032501 | Proteasomal ATPase OB C-terminal domain |
| UnnamedSample_HQ_transcript/63352|m.16702 | UnnamedSample_HQ_transcript/63352 | Coverage 0.986 too low. | 1f6ab3db8f7815f7a6481c830b96e459 | 181 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 1 | 149 | 1.2E-81 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 33 | 121 | 2.3E-13 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 449 | 539 | 2.4E-11 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 139 | 224 | 3.0E-21 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 239 | 329 | 2.9E-22 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 564 | 635 | 1.0E-7 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/56362|m.15312 | UnnamedSample_HQ_transcript/56362 | Coverage 0.455 too low. | f70ebf4ffc14d471c7cfcf69d593ba2e | 660 | Pfam | PF00028 | Cadherin domain | 344 | 435 | 4.9E-25 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/20538|m.7018 | UnnamedSample_HQ_transcript/20538 | Coverage 0.345 too low. | f0d75eb00e2a4e362cc51cbcc011f9b8 | 285 | Pfam | PF05485 | THAP domain | 96 | 165 | 4.3E-5 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/20538|m.7018 | UnnamedSample_HQ_transcript/20538 | Coverage 0.345 too low. | f0d75eb00e2a4e362cc51cbcc011f9b8 | 285 | Pfam | PF05485 | THAP domain | 9 | 76 | 2.8E-11 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/83519|m.20268 | UnnamedSample_HQ_transcript/83519 | Coverage 0.969 too low. | 715cc07e149d88e361a0bb1a817629a4 | 312 | Pfam | PF00493 | MCM P-loop domain | 1 | 92 | 6.6E-38 | T | 22-09-2020 | IPR001208 | MCM domain |
| UnnamedSample_HQ_transcript/83519|m.20268 | UnnamedSample_HQ_transcript/83519 | Coverage 0.969 too low. | 715cc07e149d88e361a0bb1a817629a4 | 312 | Pfam | PF17855 | MCM AAA-lid domain | 121 | 205 | 1.2E-30 | T | 22-09-2020 | IPR041562 | MCM, AAA-lid domain |
| UnnamedSample_HQ_transcript/8759|m.3438 | UnnamedSample_HQ_transcript/8759 | Coverage 0.925 too low. | fbe470ecb73ab270195d0b00887f3bdb | 345 | Pfam | PF14051 | N-terminal domain of DPF2/REQ. | 25 | 95 | 2.4E-36 | T | 22-09-2020 | IPR025750 | Requiem/DPF N-terminal domain |
| UnnamedSample_HQ_transcript/35387|m.10800 | UnnamedSample_HQ_transcript/35387 | Coverage 0.133 too low. | 0b3e38ae558714ce9bb15ae79996695f | 286 | Pfam | PF10358 | N-terminal C2 in EEIG1 and EHBP1 proteins | 6 | 148 | 6.6E-30 | T | 22-09-2020 | IPR019448 | NT-type C2 domain |
| UnnamedSample_HQ_transcript/9947|m.3810 | UnnamedSample_HQ_transcript/9947 | Coverage 0.432 too low. | 0b3e38ae558714ce9bb15ae79996695f | 286 | Pfam | PF10358 | N-terminal C2 in EEIG1 and EHBP1 proteins | 6 | 148 | 6.6E-30 | T | 22-09-2020 | IPR019448 | NT-type C2 domain |
| UnnamedSample_HQ_transcript/69323|m.17813 | UnnamedSample_HQ_transcript/69323 | Coverage 0.235 too low. | c4a8ca8d353cd6829bb7e55419ad73bb | 463 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.6E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/75918|m.19002 | UnnamedSample_HQ_transcript/75918 | Coverage 0.792 too low. | 5107d01af9ef00517754a91ff24b37cb | 386 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.2E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/26666|m.8639 | UnnamedSample_HQ_transcript/26666 | Identity 0.916 too low. | 1b8318b7349dc73f3d42d3ba64e1b295 | 661 | Pfam | PF01067 | Calpain large subunit, domain III | 342 | 459 | 2.2E-26 | T | 22-09-2020 | IPR022682 | Peptidase C2, calpain, large subunit, domain III |
| UnnamedSample_HQ_transcript/26666|m.8639 | UnnamedSample_HQ_transcript/26666 | Identity 0.916 too low. | 1b8318b7349dc73f3d42d3ba64e1b295 | 661 | Pfam | PF00648 | Calpain family cysteine protease | 18 | 316 | 1.5E-89 | T | 22-09-2020 | IPR001300 | Peptidase C2, calpain, catalytic domain |
| UnnamedSample_HQ_transcript/67741|m.17531 | UnnamedSample_HQ_transcript/67741 | Coverage 0.740 too low. | 765081b8355259c8674267a37de7975d | 325 | Pfam | PF13582 | Metallo-peptidase family M12B Reprolysin-like | 8 | 89 | 2.7E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/67741|m.17531 | UnnamedSample_HQ_transcript/67741 | Coverage 0.740 too low. | 765081b8355259c8674267a37de7975d | 325 | Pfam | PF17771 | ADAM cysteine-rich domain | 160 | 223 | 4.0E-12 | T | 22-09-2020 | IPR041645 | ADAM cysteine-rich domain 2 |
| UnnamedSample_HQ_transcript/46903|m.13342 | UnnamedSample_HQ_transcript/46903 | Coverage 0.617 too low. | b3675ef03687cf3c4851029e2ab54b44 | 646 | Pfam | PF02190 | ATP-dependent protease La (LON) substrate-binding domain | 10 | 63 | 4.6E-8 | T | 22-09-2020 | IPR003111 | Lon, substrate-binding domain |
| UnnamedSample_HQ_transcript/46903|m.13342 | UnnamedSample_HQ_transcript/46903 | Coverage 0.617 too low. | b3675ef03687cf3c4851029e2ab54b44 | 646 | Pfam | PF00004 | ATPase family associated with various cellular activities (AAA) | 214 | 350 | 5.0E-24 | T | 22-09-2020 | IPR003959 | ATPase, AAA-type, core |
| UnnamedSample_HQ_transcript/46903|m.13342 | UnnamedSample_HQ_transcript/46903 | Coverage 0.617 too low. | b3675ef03687cf3c4851029e2ab54b44 | 646 | Pfam | PF05362 | Lon protease (S16) C-terminal proteolytic domain | 432 | 639 | 2.5E-73 | T | 22-09-2020 | IPR008269 | Peptidase S16, Lon proteolytic domain |
| UnnamedSample_HQ_transcript/4343|m.1933 | UnnamedSample_HQ_transcript/4343 | Coverage 0.073 too low. | c8fd88fef8a531795d75e7083c3dc5f7 | 1514 | Pfam | PF17817 | PDZ domain | 732 | 804 | 2.4E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/4343|m.1933 | UnnamedSample_HQ_transcript/4343 | Coverage 0.073 too low. | c8fd88fef8a531795d75e7083c3dc5f7 | 1514 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 1439 | 1497 | 5.9E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/4343|m.1933 | UnnamedSample_HQ_transcript/4343 | Coverage 0.073 too low. | c8fd88fef8a531795d75e7083c3dc5f7 | 1514 | Pfam | PF00595 | PDZ domain | 813 | 895 | 1.3E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/81761|m.19991 | UnnamedSample_HQ_transcript/81761 | Coverage 0.733 too low. | f42296cf575356b107e31b3e853791f7 | 371 | Pfam | PF00651 | BTB/POZ domain | 199 | 307 | 3.2E-26 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/37042|m.11179 | UnnamedSample_HQ_transcript/37042 | Coverage 0.145 too low. | 1c46163cc3c9581ec01a141a8f7512fd | 807 | Pfam | PF08366 | LLGL2 | 280 | 373 | 3.5E-30 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/37042|m.11179 | UnnamedSample_HQ_transcript/37042 | Coverage 0.145 too low. | 1c46163cc3c9581ec01a141a8f7512fd | 807 | Pfam | PF00400 | WD domain, G-beta repeat | 384 | 454 | 0.21 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/55861|m.15207 | UnnamedSample_HQ_transcript/55861 | Unmapped. | 11afca8c26013adfcb42223b8f3a7953 | 314 | Pfam | PF00698 | Acyl transferase domain | 7 | 283 | 3.0E-38 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/52255|m.14497 | UnnamedSample_HQ_transcript/52255 | Unmapped. | 11afca8c26013adfcb42223b8f3a7953 | 314 | Pfam | PF00698 | Acyl transferase domain | 7 | 283 | 3.0E-38 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/57175|m.15483 | UnnamedSample_HQ_transcript/57175 | Coverage 0.119 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 4.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/57175|m.15483 | UnnamedSample_HQ_transcript/57175 | Coverage 0.119 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 584 | 4.3E-9 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/57175|m.15483 | UnnamedSample_HQ_transcript/57175 | Coverage 0.119 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 5.1E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/53183|m.14679 | UnnamedSample_HQ_transcript/53183 | Coverage 0.124 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 4.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/53183|m.14679 | UnnamedSample_HQ_transcript/53183 | Coverage 0.124 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 584 | 4.3E-9 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
| UnnamedSample_HQ_transcript/53183|m.14679 | UnnamedSample_HQ_transcript/53183 | Coverage 0.124 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00667 | FAD binding domain | 275 | 494 | 5.1E-76 | T | 22-09-2020 | IPR003097 | Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding |
| UnnamedSample_HQ_transcript/57846|m.15623 | UnnamedSample_HQ_transcript/57846 | Coverage 0.092 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00258 | Flavodoxin | 83 | 220 | 4.4E-34 | T | 22-09-2020 | IPR008254 | Flavodoxin/nitric oxide synthase |
| UnnamedSample_HQ_transcript/57846|m.15623 | UnnamedSample_HQ_transcript/57846 | Coverage 0.092 too low. | e9de687d48b94ac53131a4a361b0dacd | 596 | Pfam | PF00175 | Oxidoreductase NAD-binding domain | 529 | 584 | 4.3E-9 | T | 22-09-2020 | IPR001433 | Oxidoreductase FAD/NAD(P)-binding |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
